Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ: RARE · Real-Time Price · USD

22.72

+0.89 (4.08%)

At close: Feb 20, 2026, 4:00 PM EST

22.28

-0.44 (-1.94%)

After-hours: Feb 20, 2026, 7:20 PM EST

Ultragenyx Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,191	2,215	3,882	3,926	3,248	5,732
Market Cap Growth	-47.71%	-42.94%	-1.13%	20.88%	-43.33%	-37.41%
Enterprise Value	2,706	2,638	3,991	4,355	3,149	5,183
Last Close Price	22.72	23.00	42.07	47.82	46.33	84.09
PS Ratio	3.26	3.29	6.93	9.04	8.94	16.31
PB Ratio	-	137.08	14.80	14.26	9.21	6.21
P/TBV Ratio	-	-	119.17	60.65	21.95	7.67
EV/Sales Ratio	4.02	3.92	7.12	10.03	8.67	14.75
Debt / Equity Ratio	53.41	53.41	3.47	3.39	2.57	0.43
Net Debt / Equity Ratio	25.73	25.73	0.63	0.57	0.03	-0.66
Net Debt / EBITDA Ratio	-0.83	-0.83	-0.33	-0.29	-0.02	1.64
Net Debt / FCF Ratio	-	-	-0.39	-0.30	-0.02	1.47
Asset Turnover	-	-	0.37	0.29	0.24	0.21
Inventory Turnover	-	-	19.62	22.84	34.15	35.05
Quick Ratio	-	-	2.13	2.32	3.04	4.33
Current Ratio	-	-	2.37	2.61	3.38	4.72
Return on Equity (ROE)	-412.99%	-412.99%	-211.71%	-193.22%	-110.96%	-43.72%
Return on Assets (ROA)	-	-	-22.37%	-23.43%	-26.44%	-14.54%
Return on Capital Employed (ROCE)	-	-	-46.20%	-47.00%	-50.50%	-28.50%
Earnings Yield	-26.25%	-25.96%	-14.66%	-15.45%	-21.78%	-7.92%
FCF Yield	-	-	-10.86%	-13.22%	-15.29%	-7.18%
Buyback Yield / Dilution	-8.90%	-8.90%	-23.11%	-5.19%	-3.13%	-11.42%

Updated Feb 12, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q